BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 25090921)

  • 1. Immunolocalization of human alpha-synuclein in the Thy1-aSyn ("Line 61") transgenic mouse line.
    Delenclos M; Carrascal L; Jensen K; Romero-Ramos M
    Neuroscience; 2014 Sep; 277():647-64. PubMed ID: 25090921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral Deficits and Brain α-Synuclein and Phosphorylated Serine-129 α-Synuclein in Male and Female Mice Overexpressing Human α-Synuclein.
    Gabrielyan L; Liang H; Minalyan A; Hatami A; John V; Wang L
    J Alzheimers Dis; 2021; 79(2):875-893. PubMed ID: 33361597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of α-synuclein in teleost central nervous system: immunohistochemical and Western blot evidence by 3D5 monoclonal antibody in the common carp, Cyprinus carpio.
    Vaccaro R; Toni M; Casini A; Vivacqua G; Yu S; D'este L; Cioni C
    J Comp Neurol; 2015 May; 523(7):1095-124. PubMed ID: 25488013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olfactory neuron-specific expression of A30P α-synuclein exacerbates dopamine deficiency and hyperactivity in a novel conditional model of early Parkinson's disease stages.
    Nuber S; Petrasch-Parwez E; Arias-Carrión O; Koch L; Kohl Z; Schneider J; Calaminus C; Dermietzel R; Samarina A; Boy J; Nguyen HP; Teismann P; Velavan TP; Kahle PJ; von Hörsten S; Fendt M; Krüger R; Riess O
    Neurobiol Dis; 2011 Nov; 44(2):192-204. PubMed ID: 21767644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel α-synuclein-GFP mouse model displays progressive motor impairment, olfactory dysfunction and accumulation of α-synuclein-GFP.
    Hansen C; Björklund T; Petit GH; Lundblad M; Murmu RP; Brundin P; Li JY
    Neurobiol Dis; 2013 Aug; 56():145-55. PubMed ID: 23643841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic exposure to manganese decreases striatal dopamine turnover in human alpha-synuclein transgenic mice.
    Peneder TM; Scholze P; Berger ML; Reither H; Heinze G; Bertl J; Bauer J; Richfield EK; Hornykiewicz O; Pifl C
    Neuroscience; 2011 Apr; 180():280-92. PubMed ID: 21333719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters.
    Rockenstein E; Mallory M; Hashimoto M; Song D; Shults CW; Lang I; Masliah E
    J Neurosci Res; 2002 Jun; 68(5):568-78. PubMed ID: 12111846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher levels of myelin phospholipids in brains of neuronal α-Synuclein transgenic mice precede myelin loss.
    Grigoletto J; Pukaß K; Gamliel A; Davidi D; Katz-Brull R; Richter-Landsberg C; Sharon R
    Acta Neuropathol Commun; 2017 May; 5(1):37. PubMed ID: 28482862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.
    Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease.
    Williams GP; Schonhoff AM; Jurkuvenaite A; Thome AD; Standaert DG; Harms AS
    J Neuroinflammation; 2018 Aug; 15(1):244. PubMed ID: 30165873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propagation of pathological α-synuclein in marmoset brain.
    Shimozawa A; Ono M; Takahara D; Tarutani A; Imura S; Masuda-Suzukake M; Higuchi M; Yanai K; Hisanaga SI; Hasegawa M
    Acta Neuropathol Commun; 2017 Feb; 5(1):12. PubMed ID: 28148299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Convergence of heat shock protein 90 with ubiquitin in filamentous alpha-synuclein inclusions of alpha-synucleinopathies.
    Uryu K; Richter-Landsberg C; Welch W; Sun E; Goldbaum O; Norris EH; Pham CT; Yazawa I; Hilburger K; Micsenyi M; Giasson BI; Bonini NM; Lee VM; Trojanowski JQ
    Am J Pathol; 2006 Mar; 168(3):947-61. PubMed ID: 16507910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.
    Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS
    Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of different promoters on the expression pattern of mutated human alpha-synuclein in transgenic mice.
    Maskri L; Zhu X; Fritzen S; Kühn K; Ullmer C; Engels P; Andriske M; Stichel CC; Lübbert H
    Neurodegener Dis; 2004; 1(6):255-65. PubMed ID: 16908976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The temporal expression pattern of alpha-synuclein modulates olfactory neurogenesis in transgenic mice.
    Schreglmann SR; Regensburger M; Rockenstein E; Masliah E; Xiang W; Winkler J; Winner B
    PLoS One; 2015; 10(5):e0126261. PubMed ID: 25961568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct region-specific alpha-synuclein oligomers in A53T transgenic mice: implications for neurodegeneration.
    Tsika E; Moysidou M; Guo J; Cushman M; Gannon P; Sandaltzopoulos R; Giasson BI; Krainc D; Ischiropoulos H; Mazzulli JR
    J Neurosci; 2010 Mar; 30(9):3409-18. PubMed ID: 20203200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter.
    Matsuoka Y; Vila M; Lincoln S; McCormack A; Picciano M; LaFrancois J; Yu X; Dickson D; Langston WJ; McGowan E; Farrer M; Hardy J; Duff K; Przedborski S; Di Monte DA
    Neurobiol Dis; 2001 Jun; 8(3):535-9. PubMed ID: 11442360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olfactory deficits in mice overexpressing human wildtype alpha-synuclein.
    Fleming SM; Tetreault NA; Mulligan CK; Hutson CB; Masliah E; Chesselet MF
    Eur J Neurosci; 2008 Jul; 28(2):247-56. PubMed ID: 18702696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visualization of early oligomeric α-synuclein pathology and its impact on the dopaminergic system in the (Thy-1)-h[A30P]α-syn transgenic mouse model.
    Behere A; Thörnqvist PO; Winberg S; Ingelsson M; Bergström J; Ekmark-Lewén S
    J Neurosci Res; 2021 Oct; 99(10):2525-2539. PubMed ID: 34292621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice.
    Schell H; Hasegawa T; Neumann M; Kahle PJ
    Neuroscience; 2009 Jun; 160(4):796-804. PubMed ID: 19272424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.